Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when RDNT files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: RDNT RadNet, Inc. 8-K

RadNet secures $250M term loan for acquisitions, cuts interest rates 0.25%

Filed June 10, 2026 · Period ending June 10, 2026 · ~1 min read

4 key changes 2 high relevance 1 section

Key Changes

  • high

    RadNet obtained $250M incremental term loan maturing April 2031, bringing total term debt to ~$1.2B ($958.7M existing + $250M new). Quarterly principal payments rise from $2.4M to $3.1M.

    Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR →
  • high

    Proceeds earmarked for acquisitions, organic expansion, and health system partnerships. Combined with $455M cash (March 31, 2026), RadNet has substantial liquidity for growth.

    Exhibit 99.1 view on EDGAR →
  • medium

    Interest rate reduced 0.25% on term loan (now SOFR+2.00% or base+1.00%) and undrawn $282M revolver, lowering borrowing costs across the credit facility.

    Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR →
  • low

    Six-month call protection granted to lenders participating in the repricing, standard concession preventing early refinancing during that period.

    Exhibit 99.1 view on EDGAR →

Summary

RadNet closed a $250 million incremental term loan that extends its existing credit facility through April 2031. The new borrowing increases total term debt to approximately $1.2 billion and raises quarterly principal payments by $700,000 to $3.1 million. Simultaneously, the company negotiated a 0.25% interest rate reduction on both the term loan and its undrawn $282 million revolver, lowering its cost of capital.

The company disclosed it will deploy the proceeds toward acquisitions, organic expansion, and health system partnerships—continuing its growth strategy in diagnostic imaging. With $455 million in cash as of March 31, 2026, RadNet now has substantial liquidity to execute on these initiatives. The rate reduction reflects improved credit terms and will reduce interest expense on the larger debt balance. The six-month call protection granted to lenders is a standard feature in repricing transactions and prevents the company from refinancing at lower rates during that window.

Section-by-Section Diff

Event · Item 1.01 — Entry into a Material Definitive Agreement

~600 words

RadNet secured $250M incremental term loan with reduced interest rates, extending existing credit facility for acquisitions and expansion.

2 Added
Added Incremental term loan borrowing high

Added in current filing · verify on EDGAR →

certain Lenders agreed to provide the Borrower an Incremental Term Commitment (as defined by the Existing Credit Agreement) in an aggregate principal amount of $250.0 million (the “2026 Incremental Term Loan”), which will be added to and form a part of the existing term loan under the Existing Credit Agreement (the “Existing Term Loan,” together with the 2026 Incremental Term Loan, the “Term Loan”).

RadNet obtained $250 million in new term loan commitments that will be added to its existing term loan facility. The new borrowing increases the company's total term loan debt and provides capital for growth initiatives.

Added Use of proceeds medium

Added in current filing · verify on EDGAR →

Borrower plans to use the proceeds from the 2026 Incremental Term Loan for future acquisitions, organic expansion initiatives, health system partnerships, and general corporate purposes.

The company disclosed it will deploy the $250 million toward acquisitions, organic expansion, health system partnerships, and general corporate purposes. This signals continued growth strategy in the diagnostic imaging sector.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Jun 21, 2026 · How we verify